Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Douglas Wright

Undersea and Hyperbaric Medicine Show Low, AZ Doctor of Osteopathy

NPI 1659358059 CMS profile 74360

2200 E Show Low Lake Rd, Show Low, AZ 85901

Open in the dashboard

General payments

$1,151

47 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Douglas Wright of Show Low, AZ is reported in the CMS Open Payments database as having received $1,151 across 47 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $246 12
2024 General $155 7
2023 General $85 5
2022 General $145 6
2021 General $295 10
2020 General $100 5
2019 General $124 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Wright
  • Undersea and Hyperbaric Medicine median
  • Middle half of Undersea and Hyperbaric Medicine
  • National median

In program year 2025, general payments to Douglas Wright were reported at $246. Among 65 Undersea and Hyperbaric Medicine profiles paid that year, the median was $153 and the middle half received between $68 and $340.

Show as a table
Year Douglas Wright Undersea and Hyperbaric Medicine median Middle half National median
2019 $124 $162 $85–$376 $163
2020 $100 $111 $46–$307 $114
2021 $295 $154 $50–$306 $132
2022 $145 $122 $40–$378 $149
2023 $85 $145 $52–$410 $160
2024 $155 $146 $80–$316 $164
2025 $246 $153 $68–$340 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $624 21 payments
  2. Organogenesis Inc. $244 9 payments
  3. Urgo Medical North America, LLC $88 5 payments
  4. Kerecis Limited $46 4 payments
  5. Paratek Pharmaceuticals, Inc. $45 3 payments
  6. BSN Medical Inc $32 1 payment
  7. Integra LifeSciences Corporation $25 1 payment
  8. Medela LLC $16 1 payment
  9. Next Science LLC $16 1 payment
  10. Tactile Systems Technology Inc $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,151 47 payments
Products named General payments · program years 2019–2025
  1. GRAFIX PL Other Advanced Wound Management $231 6 payments
  2. OASIS $149 5 payments
  3. Puraply $119 7 payments
  4. Apligraf $92 1 payment
  5. GRAFIX PL Other Advanced Wound Management $63 2 payments
  6. URGOK2 $53 3 payments
  7. NUZYRA $45 3 payments
  8. STRAVIX $43 2 payments
  9. URGOCLEAN AG $35 2 payments
  10. GRAFIX $35 1 payment
  11. Other $587 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

226

Median for Family Practice: 1,826

Drug cost

$4,142

Median for Family Practice: $120,094

Branded share of claims

44.2%

Median for Family Practice: 18.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 100 $1,807
Meropenem Generic 13 $858
Doxycycline Hyclate Generic 54 $779
Triamcinolone Acetonide Generic 30 $481
Levofloxacin Generic 29 $216

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$106,173

Medicare's payments for the services billed

Medicare patients

114

Average age 75

Services billed

1,838

52 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Diabetes 52%
Ischemic heart disease 39%
Atrial fibrillation 37%
Chronic kidney disease 37%
Depression 27%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

47 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Undersea and Hyperbaric Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record